ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Patrick Burnett sold $158K of Arcutis Biotherapeutics, Inc.
Sold$158,320
$25.18Price
6,287Shares
−5%Stake
What ARQT did after the filing
- The stock from Wed, Mar 4 open, $23.45
- +3.2%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Apr 16 close.
Traded Mon, Mar 2. Filed Tue, Mar 3, 8:41 PM ET, after the close. Returns use the Mar 4 open and the Apr 16 close. Not investment advice.